Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study
© Brown et al; licensee Springer. 2012
Received: 9 January 2012
Accepted: 4 April 2012
Published: 4 May 2012
Patients with severe sepsis or septic shock often exhibit significant cardiovascular dysfunction. We sought to determine whether severity of diastolic dysfunction assessed by transthoracic echocardiography (TTE) predicts 28-day mortality.
In this prospective, observational study conducted in two intensive care units at a tertiary care hospital, 78 patients (age 53.2 ± 17.1 years; 51% females; mean APACHE II score 23.3 ± 7.4) with severe sepsis or septic shock underwent TTE within 6 h of ICU admission, after 18 to 32 h, and after resolution of shock. Left ventricular (LV) diastolic dysfunction was defined according to modified American Society of Echocardiography 2009 guidelines using E, A, and e’ velocities; E/A and E/e’; and E deceleration time. Systolic dysfunction was defined as an ejection fraction < 45%.
Twenty-seven patients (36.5%) had diastolic dysfunction on initial echocardiogram, while 47 patients (61.8%) had diastolic dysfunction on at least one echocardiogram. Total mortality was 16.5%. The highest mortality (37.5%) was observed among patients with grade I diastolic dysfunction, an effect that persisted after controlling for age and APACHE II score. At time of initial TTE, central venous pressure (CVP) (11+/- 5 mmHg) did not differ among grades I-III, although patients with grade I received less intravenous fluid.
LV diastolic dysfunction is common in septic patients. Grade I diastolic dysfunction, but not grades II and III, was associated with increased mortality. This finding may reflect inadequate fluid resuscitation in early sepsis despite an elevated CVP, suggesting a possible role for TTE in sepsis resuscitation.
KeywordsSepsis echocardiography Diastolic dysfunction Shock
Cardiovascular dysfunction is a central component of the multiple organ dysfunction syndrome, an often fatal sequela of severe sepsis and septic shock. Although most research on cardiovascular dysfunction in septic shock has focused on left ventricular (LV) systolic dysfunction [1–5], LV diastolic dysfunction also occurs [6, 7]. In sepsis, cardiac dysfunction reflects both intrinsic dysfunction and the adequacy of loading conditions, including both preload and afterload. Intrinsic LV diastolic dysfunction may make patients more sensitive to volume expansion interventions, often termed fluid resuscitation and often guided by central venous pressure (CVP). This sensitivity to resuscitation may be particularly prominent among patients with more severe LV diastolic dysfunction, which is generally associated with elevated left-sided filling pressures.
LV diastolic dysfunction is common and well characterized in community-dwelling adults with cardiovascular disease and is associated with significant morbidity and mortality in patients with either normal or reduced systolic function [13–16]. Much less is known about LV diastolic dysfunction in severe sepsis and septic shock. Previous studies on LV diastolic dysfunction in patients with severe sepsis and septic shock have employed various definitions and have not yielded a stable estimate of incidence [6, 7, 17–19]. Some reports suggest that the presence of LV diastolic dysfunction may be associated with poor outcome [20, 21], while others suggest no effect on outcomes [17, 18]. The natural evolution of diastolic dysfunction and its clinical implications during the course of sepsis and septic shock are also not well characterized.
We prospectively evaluated LV diastolic dysfunction among patients presenting to the ICU with severe sepsis or septic shock, with special emphasis on the different grades of diastolic dysfunction. We hypothesized that septic patients with more severe LV diastolic dysfunction would have worse outcomes.
This prospective, observational study was conducted between September 2008 and April 2010 at the Intermountain Medical Center, an academic, tertiary care hospital in Murray, UT, USA. Patients admitted to the 24-bed Shock Trauma Intensive Care Unit or the 12-bed Respiratory ICU were eligible for the study. The Intermountain Medical Center Institutional Review Board approved this study. All patients or their legally authorized representatives provided written, informed consent.
Study investigators screened patients admitted to study ICUs with severe sepsis or septic shock defined by the American College of Chest Physicians/Society of Critical Care Medicine consensus criteria . Patients met criteria for inclusion if (1) they were at least 14 years of age, (2) they had a suspected infection, (3) they had two or more systemic inflammatory response syndrome criteria, and (4) either (a) had severe sepsis (end-organ dysfunction) or (b) had septic shock (a systolic blood pressure less than 90 mmHg despite an intravenous fluid challenge of at least 20 ml/kg with evidence of organ dysfunction or hyperlactatemia. Exclusion criteria were primary diagnosis of acute coronary syndrome or major cardiac dysrhythmia, presence of pericardial tamponade, presence of mitral stenosis, known diagnosis of severe pulmonary hypertension, lack of sinus rhythm during initial echocardiogram, contraindication to central venous catheterization, or lack of commitment to intensive therapy.
Patients were treated according to the Surviving Sepsis Guidelines . Specifically, in those patients requiring a central venous catheter, treatment followed an early goal-directed therapy protocol, targeting a mean arterial pressure of ≥ 65 mm Hg, CVP ≥ 8 mmHg, and central venous oxygen saturation ≥ 70% .
Serial transthoracic echocardiograms (TTEs) were performed using either a Philips SONOS 5500, iE-33, or CX-50 (Philips Medical Systems, Bothell, WA, USA). We performed the first TTE within the first 6 h of admission to the ICU, the second at 18–32 h after admission, and the third at least 24 h after cessation of vasoactive medications or resolution of severe sepsis in patients who did not require vasoactive medications. Where a TTE was performed for clinical reasons, we analyzed the clinical TTE. In all other cases, investigators performed research TTEs, which were not employed in the clinical care of patients. All TTEs were interpreted by the second author, and a consensus interpretation was provided by one of two level-II echocardiographers (SMB, CKG) who are testamurs of the National Board of Echocardiography.
Diastolic function was assessed by measuring E and A peak velocities using spectral Doppler of mitral inflow and e’ and a’ velocities using tissue Doppler of the septal mitral annulus in the apical four-chamber view. Each data point represents the average of measurements from three consecutive cardiac cycles. In patients with sinus tachycardia, E and e’ were determined by previously described methods [25–27]. Mitral deceleration time (DT) and left atrial (LA) area at end systole were also measured. We defined diastolic dysfunction according to the American Society of Echocardiography (ASE) 2009 guidelines , classifying subjects into grade 0 (normal) if e’ ≥ 8 cm/s; grade I (impaired relaxation) if e’ < 8 cm/s and E/A < 0.8; grade II (pseudonormal) if e’ < 8 cm/s, E/A 0.8-1.5, and E/e’ 9–12; and grade III (restrictive) if e’ < 8 cm/s, E/A > 2, DT < 160 ms, and E/e’ ≥ 13 (Figure 1). The ASE guidelines were modified in that LA size was not used to define diastolic function because LA enlargement is most likely a slowly developing adaptation to chronically elevated LV filling pressures and not a reflection of acute diastolic dysfunction. In a sensitivity analysis, we evaluated the definition of diastolic dysfunction proposed by Sturgess et al. . LV systolic dysfunction was defined as an LV ejection fraction (EF) < 45% .
CVP was measured at the time of each TTE if the patient had a central venous catheter in place. Vital signs, mechanical ventilation parameters, and doses of vasoactive medications were recorded. Current intravenous fluid administration rate as well as total volume infused and total urine output in the period leading up to the TTE were obtained. All-cause inpatient mortality, ICU-free days, and ventilator-free days  at 28 days for all enrolled patients were determined. APACHE II scores at the time of ICU admission and for the day on which each TTE was performed were calculated . Patient demographics and body mass index were also recorded at the time of study enrollment.
We assessed the incidence of LV diastolic dysfunction on first or subsequent TTE as well as the relationship between LV diastolic dysfunction on the initial TTE and 28-day outcomes. Our primary outcome was 28-day mortality, with secondary outcomes of ventilator-free days and ICU-free days.
We evaluated the evolution of diastolic function through time and the relationship with inpatient mortality, ventilator-free days, and ICU-free days. We also evaluated the concordance of various proposed definitions of diastolic dysfunction. We also evaluated the incidences of LV systolic and isolated diastolic dysfunctions.
Central tendencies were compared using Fisher's exact test, Student's t test, Wilcoxon rank-sum, and Kruskal-Wallis test where appropriate. Where ties made Wilcoxon rank-sum problematic, we employed a permutation technique equivalent to one-way analysis of variance (R package coin). Regression models were built to predict mortality, ventilator-free days, and ICU-free days. All analyses were performed using the R Statistical Package (2.11.0) .
Clinical and demographic findings
Demographics and clinical findings
Age (years ± SD)
53.2 ± 17.1
APACHE II (score ± SD)
23.3 ± 7.4
Ever received vasopressor infusion (%)
Ever received mechanical ventilation (%)
MAP at admission (mmHg, median, IQR)
Highest PEEP (cm H20)
Source of infection (%):
Central nervous system
Two hundred four TTEs were performed on the 78 patients. The initial echocardiogram was performed in all 78 patients. The second echocardiogram was performed in 69 of 75 patients still alive and in the hospital on the second hospital day, while the third echocardiogram was performed in 57 of 73 patients who remained alive and in the hospital. Due to the inherent limitations of TTE, not all patients had evaluable diastolic dysfunction. Nonetheless, complete diastolic function was evaluable in 74 of 78 patients (94.8%) on the first echocardiogram, in 67 of 69 patients (97.1%) on the second, and in 53 of 57 patients (93.0%) on the third.
LV diastolic dysfunction and clinical outcomes
Incidence and clinical characteristics of diastolic dysfunction by ASE guidelines on initial echocardiogram
Grade 0 (normal)
Grade I (impaired relaxation)
Grade II (pseudonormal)
Grade III (restrictive)
p value (any difference among groups)
p value (grade I vs grades II and III)
Patients (N, %)
Median age (years)
Percent on vasopressors
IVC diameter (cm)
IVC collapsibility (%)
Cardiac output (L/min)
IVF administered prior to TTE #1 (L)
IVF administered in 24 h after TTE #1 (L)
CVP (mm Hg)
Patients with grade I diastolic dysfunction had similar CVPs (p = 0.89) compared to patients with grade II or higher diastolic dysfunction (Table 2). Patients with grade I diastolic dysfunction received significantly less volume expansion prior to the initial echocardiogram than patients with grade II or higher diastolic dysfunction (p = 0.05). Amount of volume expansion after initial echocardiogram did not differ among the different grades of diastolic dysfunction.
Incidence of diastolic dysfunction
Incidence of diastolic dysfunction by serial TTE and by definition employed
TTE #1 (0–6 h)
TTE #2 (18–32 h)
TTE #3 (post-shock)
Definition of diastolic dysfunction
Percentage abnormal (%)
Percentage abnormal (%)
Percentage abnormal (%)
Full ASE definition
e’ < 9.6 cm/s or E/e’ >15 (Fischer et al. )
Clinical and echocardiographic findings based on presence of systolic and/or diastolic dysfunction
Systolic dysfunction (LVEF < 45 %)
Isolated diastolic dysfunction (grades I, II, and III)
Patients (N, %)
36 (50 %)
19 (26.4 %)
17 (23.6 %)
Age (years, mean)
APACHE II (mean)
BMI (kg/m2, median)
e’ (cm/sec, median)
DT (ms, median)
VFD (days, mean)
ICU-free days (median)
28-day mortality (mean)
Evolution of diastolic dysfunction
Of the 27 patients with LV diastolic dysfunction on initial echocardiogram, 9 (33%) had normal diastolic function on their final echocardiogram. Of the 47 patients with normal diastolic function on their initial echocardiogram, 11 (23.4%) displayed LV diastolic dysfunction on the final echocardiogram. Patients whose initial LV diastolic dysfunction improved by the third echocardiogram were younger than patients whose LV diastolic dysfunction persisted (38 years vs 63.5 years, p < 0.01). Patients who developed LV diastolic dysfunction between the first and last echocardiogram were not significantly older (54 years vs 52 years) than those whose LV diastolic function remained normal. Neither development nor resolution of LV diastolic dysfunction over the course of severe sepsis or septic shock was associated with a difference in mortality, ventilator-free days, or ICU-free days.
This study is, to our knowledge, the largest prospective evaluation of LV diastolic dysfunction by TTE in patients admitted to the ICU for severe sepsis or septic shock. LV diastolic dysfunction is relatively common during severe sepsis and septic shock with 34.6% and 61.8% of the cohort showing evidence of LV diastolic dysfunction on admission or at some point during their clinical course of sepsis, respectively. Notably, grade I diastolic dysfunction (generally felt to indicate a relatively low left atrial pressure) was associated with worse outcome when compared with grade II or III diastolic dysfunction. This novel finding was not consistent with our original hypothesis.
The current study is in conflict with a single previous study that suggested worse outcome with more severe LV diastolic dysfunction . The reason for this discrepancy may be related to patient population, treatment algorithms, timing of the TTE, or definition of diastolic dysfunction employed. Our study specifically suggests that among patients presenting to the ICU with impaired diastolic function, those with low filling pressures as assessed by TTE have worse outcome than patients with LV diastolic dysfunction and higher filling pressures. The epidemiology and implications of diastolic dysfunction during critical illness appear to be quite different from that among community dwellers with stable disease or patients with acute cardiovascular disease (decompensated congestive heart failure or myocardial infarction). A similar effect has been observed in LV systolic function with a lower left ventricular ejection fraction associated with better survival in sepsis [1, 4], although there was no difference in mortality in our cohort of patients with normal versus low LV systolic function.
Rivers and colleagues' pivotal study of early aggressive optimization of oxygen delivery in patients with severe sepsis or septic shock suggested that initial resuscitation was crucial to outcome . That pivotal study, however, relied upon CVP to assess adequacy of volume expansion, a measurement that has been criticized on grounds that CVP poorly predicts an increase in cardiac output after volume expansion [33–35]. In our study, the mean CVP among those patients with grade I diastolic dysfunction was the same as that among patients with grade II or III diastolic dysfunction. Our study suggests that there may exist a group of patients with grade I diastolic dysfunction on TTE who would benefit from further volume expansion despite an elevated CVP. While small numbers in the subgroup of patients with grade I diastolic dysfunction limit generalizability, the higher mortality and lesser volume expansion prior to ICU admission suggest that further volume resuscitation in this group may improve survival. This study may provide equipoise for an interventional study of echocardiographic versus CVP-driven volume expansion among patients with early severe sepsis or septic shock.
Our study also highlights the need to establish a consistent, reproducible definition of LV diastolic dysfunction among critically ill patients, especially those with severe sepsis or septic shock. Prior studies report a varied incidence of LV diastolic dysfunction in patients with severe sepsis or septic shock, which may reflect a difference in patient populations and different definitions of diastolic dysfunction. In a retrospective review of 94 general ICU patients, Sturgess et al. reported an incidence of LV diastolic dysfunction equal to 67% . Applying Sturgess and colleagues' definition to our cohort, we found a relatively consistent incidence of LV diastolic dysfunction on the initial echocardiogram of 61.7%. In a small study of 35 patients with septic shock requiring mechanical ventilation, Etchecopar-Chevreuil et al. found that LV diastolic dysfunction occurred in 20% of patients . Bouhemad et al. reported a 20% incidence of isolated LV diastolic dysfunction in 54 post-operative patients with septic shock using transesophageal echocardiography . Left atrial size is often used as a criterion for diagnosing LV diastolic dysfunction . However, left atrial enlargement is most likely a slowly developing adaptation to chronically elevated LV filling pressures . In the case of sepsis, diastolic abnormalities are frequently acute, and LA enlargement is not expected to occur rapidly. Therefore, LA size is not likely to be a reliable marker of diastolic filling abnormalities in this specific condition. Because of this, we chose to rely on the Doppler assessment of LV function and filling in this study.
The natural history of LV diastolic dysfunction in our cohort from the time of ICU admission to resolution of sepsis was variable, as some patients developed diastolic dysfunction over the course of their sepsis and others resolved their diastolic dysfunction. This finding is incongruent with other studies reporting that diastolic dysfunction in sepsis is transient and reversible [17, 18]. Due to the continually changing physiologic profile of patients with severe sepsis and septic shock, the clinical importance of this finding is unclear. Future studies with classification of patients by age and grade of diastolic dysfunction should help clarify the evolution and clinical implication of LV diastolic dysfunction in severe sepsis and septic shock.
The limitations of this study include its observational nature. We used both research and clinical TTEs for our analyses. Clinicians were blinded to the research TTEs, but the clinical TTEs may have influenced clinical management. However, fluid management after the initial echocardiogram, which was similar regardless of degree of diastolic dysfunction, does not suggest that knowledge of the TTE changed management. Additionally, we chose to define diastolic dysfunction by the ASE 2009 guidelines, which were not developed for patients with sepsis. Furthermore, we specifically measured tissue Doppler of the septal annulus which may overestimate the severity of diastolic dysfunction . While other measures of diastolic function are available, such as the indexed left atrial volume and/or the ratio of the diastolic reversal in pulmonary inflow to mitral A inflow duration [37, 38], pulmonary inflow is difficult to obtain reliably in critically ill patients, and in our cohort, left atrial dilatation was extremely rare. The relatively small number of patients in patient subgroups underscores the importance of much larger sample sizes for studies in critical care echocardiography than have been reported to date. In addition, the study investigators are level-II echocardiographers. Whether the same observations would obtain in healthcare settings with less-trained critical care echocardiographers is not known, although the markers of diastolic dysfunction investigated in this study are generally easy to learn.
Two strengths of this study are its prospective nature and its size: it is one of the largest studies to date of critical care echocardiography. We were able to obtain acceptable images and quantify LV diastolic function in 95% of these critically ill patients, many of whom are generally considered to have poor windows for TTE, suggesting that TTE is useful in critically ill patients. TTE has major advantages over transesophageal echocardiography in terms of risk to the patient and ease in performing the exam, particularly for serial studies.
LV diastolic dysfunction occurs frequently during severe sepsis and septic shock. Grade I diastolic dysfunction is associated with increased mortality when compared to either patients with normal filling patterns or those with grade II or III diastolic dysfunction. The association of worsening outcome with the less severe form of diastolic dysfunction could suggest the deleterious effect of inadequate volume expansion at the time of ICU admission. Our findings suggest that TTE may identify patients who require further fluid resuscitation during severe sepsis and septic shock despite a CVP that indicates adequate resuscitation according to current guidelines. Future clinical studies randomly comparing the use of CVP versus TTE for assessing the adequacy of fluid resuscitation are needed to confirm these findings. Further work to standardize the definitions of diastolic dysfunction in critically ill patients is also needed.
atrial diastolic mitral inflow velocity
American Society of Echocardiography
central venous pressure
early diastolic mitral inflow velocity
early diastolic septal mitral annulus velocity
left atrium/left atrial
left ventricle/left ventricular
This study was supported by grants from the Easton Family Fund and the Deseret Foundation. Dr. Brown is supported by a Career Development Award (K23GM094465) from the National Institute of General Medical Sciences. We acknowledge Naresh Kumar and Al Jephson for creating and maintaining the database; Anita Austin, Leanne Struck, and Heather Gallo for screening and consenting patients; Amanda Borba for administrative support; and Ken Horton for providing technical support for acquisition of echocardiograms.
- Jardin F, Fourme T, Page B, Loubieres Y, Vieillard-Baron A, Beauchet A, Bourdarias JP: Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest 1999,116(5):1354–1359. 10.1378/chest.116.5.1354PubMedView Article
- Kumar A, Haery C, Parrillo JE: Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. J Cardiothorac Vasc Anesth 2001,15(3):364–376. S1053-0770(01)22786-4 [pii]10.1053/jcan.2001.22317PubMedView Article
- Kumar A, Krieger A, Symeoneides S, Parrillo JE: Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. J Cardiothorac Vasc Anesth 2001,15(4):485–511. S1053-0770(01)34974-1 [pii]10.1053/jcan.2001.25003PubMedView Article
- Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984,100(4):483–490.PubMedView Article
- Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F: Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008,36(6):1701–1706. 10.1097/CCM.0b013e318174db05PubMedView Article
- Jafri SM, Lavine S, Field BE, Bahorozian MT, Carlson RW: Left ventricular diastolic function in sepsis. Crit Care Med 1990,18(7):709–714. 10.1097/00003246-199007000-00005PubMedView Article
- Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA: Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 1997,23(5):553–560. 10.1007/s001340050372PubMedView Article
- Yalcin F, Kaftan A, Muderrisoglu H, Korkmaz ME, Flachskampf F, Garcia M, Thomas JD: Is Doppler tissue velocity during early left ventricular filling preload independent? Heart 2002,87(4):336–339. 10.1136/heart.87.4.336PubMed CentralPubMedView Article
- Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA: Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997,30(6):1527–1533. S0735-1097(97)00344-6 [pii]PubMedView Article
- Combes A, Arnoult F, Trouillet JL: Tissue Doppler imaging estimation of pulmonary artery occlusion pressure in ICU patients. Intensive Care Med 2004,30(1):75–81. 10.1007/s00134-003-2039-xPubMedView Article
- Agricola E, Galderisi M, Oppizzi M, Melisurgo G, Airoldi F, Margonato A: Doppler tissue imaging: a reliable method for estimation of left ventricular filling pressure in patients with mitral regurgitation. Am Heart J 2005,150(3):610–615. S0002-8703(05)00150-X [pii]10.1016/j.ahj.2004.10.046PubMedView Article
- Bouhemad B, Nicolas-Robin A, Benois A, Lemaire S, Goarin JP, Rouby JJ: Echocardiographic Doppler assessment of pulmonary capillary wedge pressure in surgical patients with postoperative circulatory shock and acute lung injury. Anesthesiology 2003,98(5):1091–1100. 00000542-200305000-00011 [pii]PubMedView Article
- Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006,355(3):260–269. 355/3/260 [pii]10.1056/NEJMoa051530PubMedView Article
- Fischer M, Baessler A, Hense HW, Hengstenberg C, Muscholl M, Holmer S, Doring A, Broeckel U, Riegger G, Schunkert H: Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J 2003,24(4):320–328. S0195668X02004281 [pii]PubMed
- Kuznetsova T, Herbots L, Lopez B, Jin Y, Richart T, Thijs L, Gonzalez A, Herregods MC, Fagard RH, Diez J, Staessen JA: Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2009,2(2):105–112. CIRCHEARTFAILURE.108.822627[pii]10.1161/CIRCHEARTFAILURE.108.8226 27PubMedView Article
- Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ: Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003,289(2):194–202. joc21616 [pii]PubMedView Article
- Bouhemad B, Nicolas-Robin A, Arbelot C, Arthaud M, Feger F, Rouby JJ: Isolated and reversible impairment of ventricular relaxation in patients with septic shock. Crit Care Med 2008,36(3):766–774. 10.1097/CCM.0B013E31816596BC00003246-200803000-00015 [pii]PubMedView Article
- Etchecopar-Chevreuil C, Francois B, Clavel M, Pichon N, Gastinne H, Vignon P: Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study. Intensive Care Med 2008,34(2):250–256. 10.1007/s00134-007-0929-zPubMedView Article
- Sturgess DJ, Marwick TH, Joyce CJ, Jones M, Venkatesh B: Tissue Doppler in critical illness: a retrospective cohort study. Crit Care 2007,11(5):R97. cc6114 [pii] 10.1186/cc6114PubMed CentralPubMedView Article
- Munt B, Jue J, Gin K, Fenwick J, Tweeddale M: Diastolic filling in human severe sepsis: an echocardiographic study. Crit Care Med 1998,26(11):1829–1833. 10.1097/00003246-199811000-00023PubMedView Article
- Sturgess DJ, Marwick TH, Joyce C, Jenkins C, Jones M, Masci P, Stewart D, Venkatesh B: Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care 2010,14(2):R44. cc8931 [pii]10.1186/cc8931PubMed CentralPubMedView Article
- Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992,101(6):1644–1655. 10.1378/chest.101.6.1644PubMedView Article
- Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008,36(1):296–327. 10.1097/01.CCM.0000298158.12101.4100003246-200801000-00043 [pii]PubMedView Article
- Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001,345(19):1368–1377. 10.1056/NEJMoa010307PubMedView Article
- Nagueh SF, Kopelen HA, Quinones MA: Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation. Circulation 1996,94(9):2138–2145. 10.1161/01.CIR.94.9.2138PubMedView Article
- Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA: Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation 1998,98(16):1644–1650. 10.1161/01.CIR.98.16.1644PubMedView Article
- Sohn DW, Song JM, Zo JH, Chai IH, Kim HS, Chun HG, Kim HC: Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. J Am Soc Echocardiogr 1999,12(11):927–931. S0894731799000905 [pii]PubMedView Article
- Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009,22(2):107–133. 10.1093/ejechocard/jep007PubMedView Article
- Schoenfeld DA, Bernard GR: Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002,30(8):1772–1777. 10.1097/00003246-200208000-00016PubMedView Article
- Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985,13(10):818–829. 10.1097/00003246-198510000-00009PubMedView Article
- Team RDC (2009): R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2009.
- Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BL, Redfield MM: Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol 2005,45(1):87–92. S0735-1097(04)01947-3 [pii]10.1016/j.jacc.2004.09.054PubMedView Article
- Kumar A, Anel R, Bunnell E, Habet K, Zanotti S, Marshall S, Neumann A, Ali A, Cheang M, Kavinsky C, Parrillo JE: Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 2004,32(3):691–699. 10.1097/01.CCM.0000114996.68110.C9PubMedView Article
- Marik PE, Baram M, Vahid B: Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008,134(1):172–178. 10.1378/chest.07-2331PubMedView Article
- Michard F, Teboul JL: Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 2002,121(6):2000–2008. 10.1378/chest.121.6.2000PubMedView Article
- Vignon P, Allot V, Lesage J, Martaille JF, Aldigier JC, Francois B, Gastinne H: Diagnosis of left ventricular diastolic dysfunction in the setting of acute changes in loading conditions. Crit Care 2007,11(2):R43. 10.1186/cc5736PubMed CentralPubMedView Article
- Shuai XX, Chen YY, Lu YX, Su GH, Wang YH, Zhao HL, Han J: Diagnosis of heart failure with preserved ejection fraction: which parameters and diagnostic strategies are more valuable? Eur J Heart Fail 2011,13(7):737–745. 10.1093/eurjhf/hfr053PubMedView Article
- Hummel YM, Voors AA: Grading diastolic left ventricular function. Eur J Heart Fail 2011,13(7):698–699. 10.1093/eurjhf/hfr061PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.